作者: Amy L. McGuire , Laurence B. McCullough , James P. Evans
关键词:
摘要: Whole-genome sequencing and whole-exome (WGS/WES) have become increasingly affordable accessible to individuals. There are currently 3 main pathways through which a person can receive WGS/WES: as research participant in genomic study; direct-to-consumer personal genome company; or part of clinical care. In the context, extent findings from WGS/WES communicated study participants used inform their care is topic much debate, but guidelines suggest that investigators may an obligation offer at least some results participants.1